Podcasts about Lorusso

In deze aflevering blikt Benjamin alvast vooruit op Transition Festival en praat hij met zangeres en pianiste Federica Lorusso. Ze komt oorspronkelijk uit Italie en studeerde aan het Conservatorium van Den Haag, waarna ze haar Master behaalde aan het Conservatorium van Amsterdam. Ze bracht onlangs haar tweede album ‘Incontri' uit. De plaat gaat over het maken van een nieuwe connectie met haarzelf, met anderen en met de natuur.

On this episode of the Additive Insight podcast, we're joined by Roboze founder and CEO Alessio Lorusso. Lorusso assembled his first 3D printer when he was 17 years old and has since gone on to build an additive manufacturing technology supplier serving some of the biggest names in aerospace, energy and motorsport. He joins the Additive Insight podcast to provide some insight into the beginnings of Roboze, the evolution of its product portfolio and the secretes behind the company's success. We also touch on the importance of understanding customer needs and the vision he has for the future of the company.

Contradictorio que Sedena dé disculpa pública sin castigar a responsables de desaparición: LorussoEnlace para apoyar vía Patreon:https://www.patreon.com/julioastilleroEnlace para hacer donaciones vía PayPal:https://www.paypal.me/julioastilleroCuenta para hacer transferencias a cuenta BBVA a nombre de Julio Hernández López: 1539408017CLABE: 012 320 01539408017 2Tienda:https://julioastillerotienda.com/ Te invitamos a que visites nuestro perfil en Patreon. Solo da clic aquí Hosted on Acast. See acast.com/privacy for more information.

Philip welcomes Silvio Lorusso to talk about his book What Design Can't Do. In their conversation, they examine how design as a practice has changed and often fails to addresses larger social and economic issues. The Drop – The segment of the show where Philip and his guest share tasty morsels of intellectual goodness and creative musings. Philip's Drop: Quincy Jones Discography (https://open.spotify.com/artist/3rxIQc9kWT6Ueg4BhnOwRK?si=67OdhI0jRDCYyyrBMobWdQ) Silvio's Drop: Nick Cave Discography (https://open.spotify.com/artist/4UXJsSlnKd7ltsrHebV79Q?si=PxSUiPW0QAupXb53ER4mNw)

“The background for active management is as good as I've seen in a very long time,” says Vince Lorusso. He likes long-short equity strategies and highlights liquidity needs for actively managed funds. “You need to get to know your manager,” he adds. His short pick is Hershey (HSY), while his long is BWX Technologies (BWXT). ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Dr. Linda Duska and Dr. Domenica Lorusso discuss the practice-changing results of the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study, which evaluated pembrolizumab plus chemoradiotherapy as treatment for previously untreated, high-risk, locally advanced cervical cancer. TRANSCRIPT  Dr. Linda Duska: Hello, I'm Linda Duska, your guest host of the ASCO Daily News Podcast today. I'm a professor of obstetrics and gynecology and serve as the associate dean for clinical research at the University of Virginia School of Medicine. On today's episode, we'll be discussing a new standard of care for previously untreated, high- risk locally advanced cervical cancer. This follows the ENGOT-cx11/GOG-3047/KEYNOTE-A18 study, which I will be referring to as KEYNOTE-A18 for the rest of this podcast, which demonstrated that pembrolizumab plus chemoradiotherapy improved both progression-free and overall survival compared to chemoradiotherapy alone. I was a co-author of this study, and I'm delighted to be joined today by the study's lead investigator, Dr. Domenica Lorusso, for today's discussion. She is also a professor of obstetrics and gynecology. She's at Humanitas University Rosano and the director of the Gynecologic Oncology Unit at the Humanitas Hospital San Pio in Milan, Italy. Our full disclosures are available in the transcript of this episode. Dr. Lorusso, it's great to be speaking with you today. Dr. Domenica Lorusso: Thank you, Linda. It's a great pleasure to be here. Thank you. Dr. Linda Duska: So I was hoping you could start us out with some context on the challenges associated with treating patients with high-risk, locally advanced cervical cancer. Dr. Domenica Lorusso: Yes. I have to make a disclosure because in my experience as a gynecologist, cervical cancer patients are the most difficult patients to treat. This is a tumor that involves young patients [who often have] small kids. This is a very symptomatic tumor. More than 50% of patients report pain. Sometimes the pain is difficult to control because there is an infiltration of the pelvic nerves and also a kind of vaginal discharge, so it's very difficult to treat the tumor. Since more than 25 years, we have the publication of 5 randomized trials that demonstrate that when we combine platinum chemotherapy to radiation treatment, we increase overall survival by 6%. This is the new standard of care – concurrent chemoradiation plus brachytherapy. This is a good standard of care because particularly modern, image-guided radiotherapy has reported to increase local control. And local control in cervical cancer translates to better overall survival. So modern radiotherapy actually is able to cure about 75% of patients. This is what we expect with chemoradiation right now. Dr. Linda Duska: So what are the key takeaways of A18? This is a really exciting trial, and you've presented it a couple of times. Tell us what are the key takeaways that you want our listeners to know. Dr. Domenica Lorusso: Linda, this is our trial. This is a trial that we did together. And you gave me the inspiration because you were running a randomized phase 2 trial exploring if the combination of pembrolizumab to concurrent chemoradiation was able to give signals of efficacy, but also was feasible in terms of toxicity. There were several clinical data suggesting that when we combine immunotherapy to radiotherapy, we can potentially increase the benefit of radiotherapy because there is a kind of synergistic effect between the two strategies. Radiotherapy works as a primer and immunotherapy works better. And you demonstrated that it was feasible to combine immunotherapy to concurrent chemoradiation. And KEYNOTE-A18 was based on this preliminary data. We randomized about 1,060 patients to receive concurrent chemoradiation and brachytherapy or concurrent chemoradiation and brachytherapy in combination with pembrolizumab followed by pembrolizumab for about two years. Why two years? Because in more than 80% of cases, recurrence in this patient population occurred during the first two years. So the duration of treatment was based on the idea to provide protection to the patient during the maximum time of risk. And the trial had the two primary endpoints, progression free and overall survival, and met both the endpoints, a significant 30% reduction in the risk of progression that was confirmed. At the 3-year follow up, the observation was even better, 0.68. So 32% reduction in the risk of progression. And more importantly, because this is a curative setting, 33% reduction in the risk of death was reported in the experimental arm when pembro was combined with chemoradiation. Dr. Linda Duska: That's amazing. I wanted to ask you, a prior similar study called CALLA was negative. Why do you think A18 was positive? Dr. Domenica Lorusso: Linda, there are several discussions about that. I had the possibility to discuss several times with the PI of CALLA, Brad Monk. The idea of Brad is that CALLA was negative because of using durvalumab instead of PD-1 inhibitor, which is pembrolizumab. I do not have exactly the same impression. My idea is that it's the kind of patient population enrolled. The patient population enrolled in KEYNOTE-A18 was really a high-risk population; 85% of that patient were node positive, where the definition of node positivity was at least 2 lymph nodes in the pelvis with a short diameter of 1.5. So, we are very confident this patient was node-positive, 55% at the grade 3 and 4 diseases. So this is really a high-risk population. I remember at the first presentation of CALLA, I was honored to discuss the CALLA trial when it was first presented at IGCS a few years ago. And when I received the forest plot of Calla, it was evident to me that in patients with stage III and node positive there was a signal of efficacy. And we have a huge number of patients with node positive. So in my opinion this is the reason why KEYNOTE-A18 is positive. Dr. Linda Duska: Yeah, I agree with you. I've thought about it a lot and I think you're right about that. The INTERLACE trial results were recently published. How should we interpret these results in the context of A18? Dr. Domenica Lorusso: So it's very difficult to compare the 2 trials. First of all, in terms of population. The population enrolled in INTERLACE is a low-risk, locally advanced but low risk population; 76% were stage II, 10% were stage I, 60% were node-negative patients. So, first of all, the population is completely different. Second is the type of radiotherapy that was provided. INTERLACE is a 10-year long trial, but in 10 years the quality and the technique of radiotherapy completely changed. Only 30% of patients in INTERLACE received what we call the modern image-guided brachytherapy, which is important because it provides local control and local control increases overall survival. And third, we read the paper. I'm not a methodologist, but there are some methodological biases in the paper. All the statistical design of the trial was based on PFS, but PFS was evaluated at physician description. And honestly, I never saw a trial that had no pre-specified timeline for radiological evaluation. It's very difficult to evaluate progression in cervical cancer because the fibrosis related to radiotherapy changes the anatomy in the pelvis. And I think that the radiological evaluation is important to address if the patient is progressing or not. Particularly, because the conclusion of CALLA is that the PFS was mainly in favor of distant metastasis. So really, it's difficult for me to understand how distant metastasis may be evaluated with the vagina visit. So really, it's very difficult to compare the two trials, but I have some concerns. And also because of toxicity in the study, unfortunately 30% of patients did not complete concurrent chemoradiation because of residual toxicity due to induction chemotherapy. So I wanted to be sure in the context of modern radiotherapy, if really induction chemo adds something to modern radiotherapy. Dr. Linda Duska: Well, I have two more questions for you. As we move immunotherapy into the front line, at least for these high risk locally advanced cervical cancer patients that were eligible for A18, what does that mean then for hopefully those few that develop recurrence in terms of second line therapy? Dr. Domenica Lorusso: Well, Linda, this is a very important question. We do not have data about immuno after immuno, but I would not completely exclude this hypothesis because in KEYNOTE-A18, the patient received treatment for a well-defined time period. And for those patients not progressing during immunotherapy, I really guess if there is a space for the reintroduction of immunotherapy at the time of recurrence. In this moment we have 30% of patients in KEYNOTE-A18 in the control arm that receive immunotherapy after progression, but still we have 11% of patients that receive immunotherapy in combination with concurrent chemoradiation and then receive, again, immunotherapy in later line of therapy. I think we need to collect these data to capture some signals and for sure we have the new drug. We have antibody drug conjugate. The trials are ongoing exploring the role of antibody drug conjugate, particularly in immune pretreated patients. So I think this is a very interesting strategy. Dr. Linda Duska: I was going to ask you, “What are the next steps,” but I think you already answered that question. You talked about the second line. If you were going to redesign a study in the frontline, what would it look like? Dr. Domenica Lorusso: Probably one question that I would like to answer – there are two questions in my opinion in KEYNOTE-A18 – one is induction immunotherapy. Linda, correct me if I'm wrong, you reported very interesting data about the immune landscape change when you use induction immunotherapy. And I think this is something that we need to explore in the future. And the second question is the duration of maintenance. Because, again, we decided for two years based only on the epidemiology of recurrence, but I guess if one year may be enough. Dr. Linda Duska: I think this sequencing question is really important, that the induction immunotherapy was actually GY017. I can't take credit for that, but I think you're right. I think the sequencing question is really important. Whether you need the concurrent IO or not is an important question. And then to your point about the 2 years, the length of the need for maintenance therapy is a question that we don't know the answer to. So there are lots of really important questions we can continue to ask. I want to thank you so much for sharing your valuable insights with us on the podcast today. You're always so thoughtful about this particular study and cervix cancer in general and also for your great work to advance the care for patients with GYN cancers. Dr. Domenica Lorusso: Thank you, Linda. It's our work - we progress together. Dr. Linda Duska: Yes. And we thank the patients as well. The over 1,000 patients that went on this trial during a pandemic. Right? Dr. Domenica Lorusso: Absolutely. Without their generosity and their trust, we would not be able to do this trial. Dr. Linda Duska: So we're very grateful to them and we thank our listeners for your time today. If you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review and subscribe wherever you get your podcasts. Thank you all.   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.   Follow today's speakers:  Dr. Linda Duska @Lduska Dr. Domenica Lorusso   Follow ASCO on social media:   @ASCO on Twitter   ASCO on Facebook   ASCO on LinkedIn     Disclosures:   Dr. Linda Duska: Consulting or Advisory Role: Regeneron, Inovio Pharmaceuticals, Merck, Ellipses Pharma Research Funding (Inst.): GlaxoSmithKline, Millenium, Bristol-Myers Squibb, Aeterna Zentaris, Novartis, Abbvie, Tesaro, Cerulean Pharma, Aduro Biotech, Advaxis, Ludwig Institute for Cancer Research, Leap Therapeutics Patents, Royalties, Other Intellectual Property: UptToDate, Editor, British Journal of Ob/Gyn Dr. Domenica Lorusso: Consulting or Advisory Role: PharmaMar, AstraZeneca, Clovis Oncology, GSK, MSD, Genmab, Seagen, Immunogen, Oncoinvest, Corcept, Sutro Biopharma, Novartis, Novocure, Daiichi Sankyo/Lilly Speakers' Bureau: AstraZeneca, Clovis, GSK, MSD, ImmunoGen, Seagen Research Funding (Inst.): PharmMar, Clovis, GSK, MSD, AstraZeneca, Clovis Oncology, Genmab, Seagen, Immunogen, Incyte, Roche, Pharma&, Corcept Therapeutics, Alkermes Travel, Accommodations, Expenses: AstraZeneca, Clovis, GSK, Menarini  

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Domenica Lorusso to discuss  KEYNOTE-A18 Overall Survival Results: Pembrolizumab and Chemoradiotherapy. Dr. Domenica Lorusso, MD, PhD, directs the Gynaecological Oncology Unit at Humanitas Hospital, Milan, and holds a Full Professorship in Obstetrics and Gynaecology at Humanitas University, Rozzano, Milan. She has led/participated in approximately 250 phase I-IV clinical trials. Currently overseeing more than 60 studies as Principal Investigator, Dr. Lorusso also chairs the Clinical Trials Committee of the MITO Group. She serves on the Board of Directors of the GCIG and is an active member of ENGOT, where she chairs the Gynecological Cancer Academy. Additionally, she sits on the Board of Directors of the ESGO. With around 300 international oncology publications and contributions to national and international treatment guidelines, her primary objectives are to ensure optimal patient care, foster clinical research, and advance international collaborations and education in the field. Highlights:  In a phase 3 trial (ENGOT-cx11/GOG-3047/KEYNOTE-A18), pembrolizumab added to chemoradiotherapy significantly improved progression-free survival and overall survival for patients with locally advanced, high-risk cervical cancer. Patient Group: 1060 patients with FIGO 2014 stage IB2–IVA cervical cancer from 30 countries were randomized to receive pembrolizumab with chemoradiotherapy or placebo with chemoradiotherapy. Overall Survival: At a median follow-up of 29.9 months, the 36-month overall survival rate was 82.6% in the pembrolizumab group versus 74.8% in the placebo group, with a hazard ratio for death of 0.67 (95% CI 0.50–0.90; p=0.0040). Safety Profile: Grade 3 or higher adverse events were reported in 78% of pembrolizumab-treated patients versus 70% in the placebo group, with higher rates of potentially immune-mediated adverse events in the pembrolizumab group (39% vs. 17%). Conclusion: These findings confirm pembrolizumab plus chemoradiotherapy as an effective and potentially new standard of care for locally advanced cervical cancer.

In this live Q&A session, Ramos Law's aviation attorney Joe LoRusso tackles a variety of crucial topics for pilots and aviation professionals, from navigating FAA medical special issuance timelines to understanding the impact of preexisting conditions on licensing. Joe shares his thoughts on pilot responsibilities in aircraft maintenance, offers tips on legal preparedness in aviation, and provides insights into the future of aviation regulation. Whether you're a seasoned pilot, aviation student, or new to the field, gain valuable knowledge directly from an experienced aviation attorney as he addresses your top questions.

Taking a flower arranging class helped Maryann LoRusso to form a deeper connection with her mother-in-law.

Send us a textLorraine LoRusso never imagined her sister's volunteer work would lead to an extraordinary reunion with long-lost family in Italy. Join us as Lorraine shares her heartfelt story of tracing her roots back to the charming town of Vallesaccarda. These discoveries, sparked by ship records and naturalization papers, not only rekindled family ties but also brought to life the enduring legacy of her grandfather, who bravely set sail for America in 1914.We also explore the broader narrative of Italian immigrants in America, highlighting the resilience and sacrifice amidst challenges like language barriers and prejudice. Through Lorraine's personal anecdotes and our engaging discussion, you'll gain insight into the efforts to preserve family heritage and the pivotal role DNA testing plays in connecting the past and present. Listen as we reflect on the evolution of these immigrant communities, from bustling city life to settling in the suburbs, and the impact they had on future generations.Our journey extends into the sensory delights of Italian cuisine and the vibrant culture of Naples and New York City. Experience the authenticity of Italian culinary traditions, where simplicity and fresh ingredients reign supreme. Hear mesmerizing tales of navigating the bustling streets of Naples, where the skillful dance of traffic paints a lively portrait of city life. Celebrate with us the rich tapestry of Italian heritage, unveiling the stories that continue to shape our cultural identity and personal histories.Turnkey. The only thing you'll lift are your spirits.How To Cook Like a Real Italianhttps://amzn.to/3YkNjTBDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showPurchase my book "Farmers and Nobles" here or at Amazon.

"This might be the most unusual episode yet," exclaims George. Inspired by a recent deep dive on George's "Ask George" column, "How often do you find yourself mispronouncing the name of a restaurant?" the Arch Eats hosts discuss the most misprouncouend restaurant names in St. Louis. From Italian restaurants to the newcomers, learn the correct ways to pronounce these restaurants: Bacaro  Edera Vicia Dou Dou Cafe Trattoria Marcella and more! Plus, hear about George and Cheryl's favorite foods from the often-mispronounced restaurants—and even learn how to correctly pronounce dishes. Tune in for the ultimate St. Louis dining language lessson! Listen and follow Arch Eats on Apple Podcasts, Spotify, YouTube, or wherever podcasts are available. This episode is sponsored by Green Dining Alliance, an initiative of earthday365. The Green Dining Alliance is proud to present the 2024 St. Louis Food Waste Challenge happening throughout October. Learn more at greendiningalliance.org. Have an idea for a future Arch Eats episode? Send your thoughts or feedback to podcasts@stlmag.com. Hungry for more? Subscribe to our Dining newsletters for the freshest coverage on the local restaurant and culinary scene. And follow George (@georgemahe) and SLM on Instagram (@stlouismag). Interested in being a podcast sponsor? Contact Lauren Leppert at lleppert@stlmag.com. Mentioned in this episode: Sum Tea House: 8501 Olive, University City, 314-222-1540. LoRusso's Cucina – RIP: 3121 Watson, Lindenwood Park, 314-647-6222. Bacaro: 5105 Westwood, St. Peters, 636-244-0874. Acero: 7266 Manchester, Maplewood, 314-644-1790. Edera: 48 Maryland, Central West End, 314-361-7227. Vicia: 4260 Forest Park, Central West End, 314-553-9239. Peno: 7600 Wydown, Clayton, 314-899-9699. Dou Dou Café: 6318 Clayton, Richmond Heights, 314-952-2255. Pan d'Olive: 1603 McCausland, Franz Park, 314-647-8000.  Cyrano's Café: 603 East Lockwood, Webster Groves, 314-963-3232. Trattoria Marcella: 3600 Watson, Lindenwood Park, 314-352-7706. Ruth's Chris Steakhouse: Multiple Locations. Piccadilly at Manhattan: 7201 Piccadilly, Ellendale, 314-646-0016. Hot Pizza, Cold Beer: 610 Washington, Downtown, 314-696-2033. Have A Cow Cattle Company: 2742 Lafayette, The Gate, 314-261-0305. GOTham & Eggs – RIP: 3139 South Grand, South Grand, 314-833-8355. Poke Doke: Multiple Locations Nachomama's: 9643 Manchester, Rock Hill, 314-961-9110. Nudo House: Multiple Locations. Woofie's: 1919 Woodson, Overland, 314-426-6291. Yummi Tummi: 3001 S Big Bend, Maplewood, 314-833-3277. You may also enjoy these SLM articles: Ask George: How often do you find yourself mispronouncing the name of a restaurant? Ask George: Have you ever compiled a list of mispronounced foods? More episode of Arch Eats See omnystudio.com/listener for privacy information.

Dil via all'operazione di terra in Libano delle forze di Tel Aviv, è arrivata la reazione dell'Iran con la pioggia di missili sul territorio israeliano. Ma c'è stato anche un botta e risposta fra Benjamin Netanyahu e il portavoce del quartier generale delle Forze armate iraniane. L'intervista a Tiziano Marino, analista del Centro Studi internazionali (CeSI) ed esperto di Iran. 

Join Aviation Attorney and Pilot Joe LoRusso as he answers your aviation-related questions, drawing on over two decades of industry experience. Joe addresses a range of legal aviation topics, including what to do if your first-class medical is denied, steps to take if referred to HIMS, and the FAA's response to the ARC's 24 recommendations—plus much more.

 In Other News with Ethan:  LoRusso's is closing, James Darren passed, Ellen DeGeneres heading out one last time, and Own a piece of Game of Thrones

Enjoy a Capitolfest recap, an interview with Ed Lorusso who utilizes Kickstarter to release rare silent films, and a spotlight on Columbus-born actor Grant Mitchell. 

In this week's episode of Passive Income Pilots, Tait and Ryan are thrilled to have Joe LoRusso back on the show for an essential update on the evolving landscape of pilot mental health regulations. Since his last appearance, significant changes have been implemented by the FAA, including new guidelines for mental health treatments and expanded medication approvals. Joe breaks down what these changes mean for pilots navigating the complex aeromedical process. If you're a pilot or know someone facing mental health challenges, this episode is a must-listen for staying informed and protecting your medical certification. Joe LoRusso, a seasoned expert in aviation law and aeromedical regulations, returns to the show with crucial updates on FAA policy changes affecting pilot mental health. With years of experience advocating for pilots, Joe provides invaluable insights into how these new guidelines can impact your career and well-being. His dedication to helping aviators navigate the complex legal and medical landscape makes him an indispensable resource for anyone in the aviation industry.Enjoy the show!Show notes:(0:00) Intro(1:01) Joe recaps the latest FAA changes(2:43) New antidepressants added to the approved list(5:14) Guidelines for therapy and SSRIs(9:25) Impact of the Chevron doctrine on FAA regulations(13:42) Advice on choosing an informed AME(18:35) Retroactive application of new regulations(19:57) The importance of attorney-client privilege for pilots(23:37) OutroConnect with Joe LoRusso:LinkedIn: Joseph LoRusso: https://www.linkedin.com/in/josephlegal/ Explore Ramos Law Aviation: https://www.ramoslaw.com/ Follow @RamosInjuryFirm on Facebook, YouTube, and Instagram.Resources Mentioned:Guide for Aviation Medical Examiners: https://www.faa.gov/ame_guide FAA AME Guidelines: https://www.faa.gov/ame_guide/media/Anxiety_Depression_Disposition_Table.pdf Episode #51 - Navigating Turbulence: Mental Health & Legal Safeguards for Pilots with Joe LoRusso: https://passiveincomepilots.com/episode/51-navigating-turbulence-mental-health-legal-safeguards-for-pilots-with-joe-lorusso — You've found the number one resource for financial education for aviators! Please consider leaving a rating and sharing this podcast with your colleagues in the aviation community, as it can serve as a valuable resource for all those involved in the industry.Remember to subscribe for more insights at PassiveIncomePilots.com! https://passiveincomepilots.com/ Join our growing community on Facebook: https://www.facebook.com/groups/passivepilotsCheck us out on Instagram @PassiveIncomePilots: https://www.instagram.com/passiveincomepilots/Follow us on X @IncomePilots: https://twitter.com/IncomePilotsGet our updates on LinkedIn: https://www.linkedin.com/company/passive-income-pilots/Have questions or want to discuss this episode? Contact us at ask@passiveincomepilots.com See you on the next one!*Legal Disclaimer*The content of this podcast is provided solely for educational and informational purposes. The views and opinions expressed are those of the hosts, Tait Duryea and Ryan Gibson, and do not reflect those of any organization they are associated with, including Turbine Capital or Spartan Investment Group. The opinions of our guests are their own and should not be construed as financial advice. This podcast does not offer tax, legal, or investment advice. Listeners are advised to consult with their own legal or financial counsel and to conduct their own due diligence before making any financial decisions.

In Episode 089 I get into an in-depth conversation with guest Silvio Lorusso, a designer, artist, and writer based in Lisbon. Our discussion centers around the complex relationship between design, disillusionment, and the evolving role of design in society, as Silvio has articulated in his recent book 'What Design Can't Do', a critique of the rhetorical expectations placed upon design. We consider the future and past inspirations relevant to the field of Design and cover various facets of design culture, including the loss of material practices, the socio-economic impacts of design evolution, and the melancholic nostalgia among designers today. We bet into the cultural significance of memes, the backlash against crypto art, and the generational gap in the perception of technological advancements. We also get to share personal anecdotes from our professional experiences, and come to share a kind of hopeful aspiration mixed with skepticism towards the promises of modern design and technology. A fun conversation! Please rate and write a review on whatever platform you're listening right now, and support this work over on Patreon! Your support is meaningful and gratefully received. To get in touch, contact me over at Near Future Laboratory Thanks for listening! _Julian

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Domenica Lorusso to discuss the KEYNOTE A18 clinical trial. Dr. Domenica Lorusso, MD, PhD, directs the Gynaecological Oncology Unit at Humanitas Hospital, Milan, and holds a Full Professorship in Obstetrics and Gynaecology at Humanitas University, Rozzano, Milan. She has led/participated in approximately 250 phase I-IV clinical trials. Currently overseeing more than 60 studies as Principal Investigator, Dr. Lorusso also chairs the Clinical Trials Committee of the MITO Group. She serves on the Board of Directors of the GCIG and is an active member of ENGOT, where she chairs the Gynecological Cancer Academy. Additionally, she sits on the Board of Directors of the ESGO. With around 300 international oncology publications and contributions to national and international treatment guidelines, her primary objectives are to ensure optimal patient care, foster clinical research, and advance international collaborations and education in the field.   Highlights: - Concurrent chemoradiation plus brachiterapy represent the standard of care treatment in locally advanced cervical cancer providing up to 70% 5 years OS - Modern radiotherapy technique (IMRT and VMAT) has reported to further increase OS and reduce toxicity  - Immunotherapy has reported to increase OS in advanced or recurrent cervical cancer when compared to standard treatment - Immunotherapy in combination with concurrent high quality chemoradiation in the treatment of locally advanced high risk cervical cancer further increase PFS and OS with respect to standard chemoradiotherapy and should be considered the new standard of care - The combination appears manageable and no substanciad additional toxicity has been reported

On this episode, Kyle (@Sonny_108 on X) and Taylor (@DynastyPickups) discuss how to evaluate DSL performances and several new pickup recommendations. Players discussed:Leonardo PinedaTrey SweeneyNick LorussoJared SernaYeremi CabreraWe are excited to now be part of Prospects Live (@ProspectsLive)! Consider subscribing to the Patreon (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/prospectslive⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠), starting at just $5 a month, to get access to amazing tools and content such as:PLive+ Peak ProjectionsTop 1000 Dynasty Rankings (with Auction Values and League Analyzer)Top 500 Prospect RankingsTrade AnalyzerMock Draft SimulatorTop 30 team scouting reports with added fantasy contextDaily sheets (including for Spring Training, AFL, and LIDOM)Private discord channels for tier 70 and up.Additional written and audio content, including more from us!Also check out the Fantasy Baseball Discord to interact with us and many other great fantasy/dynasty/prospect minds (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://discord.gg/fantasybaseball)⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Finally please rate and review the podcast and follow us on X if you have not done so already as that would really help us out.

On this episode, Kyle (@Sonny_108 on X) and Taylor (@DynastyPickups) discuss how to evaluate DSL performances and several new pickup recommendations. Players discussed: Leonardo Pineda Trey Sweeney Nick Lorusso Jared Serna Yeremi Cabrera We are excited to now be part of Prospects Live (@ProspectsLive)! Consider subscribing to the Patreon (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/prospectslive⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠), starting at just $5 a month, to get access to amazing tools and content such as: PLive+ Peak Projections Top 1000 Dynasty Rankings (with Auction Values and League Analyzer) Top 500 Prospect Rankings Trade Analyzer Mock Draft Simulator Top 30 team scouting reports with added fantasy context Daily sheets (including for Spring Training, AFL, and LIDOM) Private discord channels for tier 70 and up. Additional written and audio content, including more from us! Also check out the Fantasy Baseball Discord to interact with us and many other great fantasy/dynasty/prospect minds (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://discord.gg/fantasybaseball)⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Finally please rate and review the podcast and follow us on X if you have not done so already as that would really help us out.

Sally Crosen and Misti Lorusso of Maid Brigade share their journey of managing a residential cleaning company, their commitment to community service, and the unique services they offer. They discuss their Maid Brigade Angels program, volunteer work, and the family-like environment they foster within their company. The conversation highlights their flexible and customizable cleaning services, their franchise model, and their dedication to providing exceptional customer service.TakeawaysMaid Brigade's commitment to community service and volunteer work is evident through their Maid Brigade Angels program and support for local schools and nonprofits.The family-like environment at Maid Brigade contributes to employee retention and a strong sense of loyalty and trust within the company.Maid Brigade offers flexible and customizable cleaning services, including laundry service, post-construction cleaning, move-in/move-out service, and organization assistance.Their franchise model allows for consistent and reliable cleaning services nationwide, with a focus on customer service and national recognition.Sound Bites"We've always been passionate about cleaning homes, but we realized that we could do so much more than cleaning.""We've done a lot of out-of-the-box cleanings. I mean, we clean, but we can clean anything.""We go into people's houses and we clean their house at no charge for four months in a row."Chapters00:00 The Maid Brigade Journey: Managing a Residential Cleaning Company03:37 Community Commitment and Volunteer Work: The Maid Brigade Angels Program08:29 Creating a Family Environment: Employee Retention and Loyalty13:00 Flexible and Customizable Cleaning Services: The Maid Brigade Approach15:18 Franchise Model and National Recognition: Maid Brigade's Nationwide Impacthttps://www.maidbrigade.com/https://thesocialcollectives.com/

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Domenica Lorusso to discuss the survival analysis of the PAOLA1 trial. Dr. Domenica Lorusso, MD, PhD, directs the Gynaecological Oncology Unit at Humanitas Hospital, Milan, and holds a Full Professorship in Obstetrics and Gynaecology at Humanitas University, Rozzano, Milan. She has led/participated in approximately 250 phase I-IV clinical trials. Currently overseeing more than 60 studies as Principal Investigator, Dr. Lorusso also chairs the Clinical Trials Committee of the MITO Group. She serves on the Board of Directors of the GCIG and is an active member of ENGOT, where she chairs the Gynecological Cancer Academy. Additionally, she sits on the Board of Directors of the ESGO. With around 300 international oncology publications and contributions to national and international treatment guidelines, her primary objectives are to ensure optimal patient care, foster clinical research, and advance international collaborations and education in the field.   Highlights: Bevacizumab plus olaparib has reported to increase PFS and OS in advanced stage III-IV, newly diagnosed, high grade serous and endometrioid HRD positive ovarian cancer in the maintenance setting  Exploratory analysis suggest that the advantage is particularly high in low risk patients (stage III withour residual tumor at primary surgery) where  a 5-year OS more  than 90% has been reported suggesting some of these patients may be cured In the HRp population the combination of olaparib-bevacizumab did non increase PFS and OS in comparison to bevacizumab alone The toxicity profile of the combination is in line with what expected with the single drugs

Join hosts Tait Duryea and Ryan Gibson on Passive Income Pilots as they engage in a profound conversation with Joe LoRusso, aviation law expert and Director of Aviation at Ramos Law. This episode takes an earnest look into pilot mental health and legal challenges, spotlighting the systemic issues and proposing a transformative approach to aviation industry norms.Joe brings invaluable dual insights from his experience in the cockpit and the courtroom. He addresses the mental health stigma, explains the intricate HIMS program, and provides expertise on dealing with DUI repercussions. This dialogue is a beacon for pilots and aviation professionals seeking to preserve their licensure, mental well-being, and explore alternative income opportunities within the aviation sector.Timestamped Show Notes:(0:00) Exploring the often overlooked subject of pilot mental health.(2:01) Joe's journey from pilot to prominent voice in aviation law.(6:35) The crucial shift to advocating for pilot rights in legal matters.(8:29) Dissecting the mental health dialogue in aviation.(18:23) The vital resources available for pilot mental health support.(25:45) Fostering pilot support networks within the aviation community.(32:42) Legal perspectives on navigating post-DUI scenarios for pilots.(37:49) Advocacy for the modernization of the HIMS program.(41:48) Tackling cardiovascular health in the context of pilot medical certifications.(43:31) Opportunities and insights within aviation law.(47:59) Connecting with Joe for guidance and advocacy.Connect with Joe LoRusso:LinkedIn: Joseph LoRussoExplore Ramos Law AviationFollow @RamosInjuryFirm on Facebook, YouTube, and Instagram.We're dedicated to guiding you along your financial flightpath. Please share this episode, leave a rating, and join us in our mission toward financial autonomy for pilots.For inquiries and feedback:Contact us at producer@passiveincomepilots.com or visit our Contact Page.https://passiveincomepilots.com/---Legal DisclaimerThe content of this podcast is provided solely for educational and informational purposes. The views and opinions expressed are those of the hosts, Tait Duryea and Ryan Gibson, and do not reflect those of any organization they are associated with, including Turbine Capital or Spartan Investment Group.The opinions of our guests are their own and should not be construed as financial advice. This podcast does not offer tax, legal, or investment advice. Listeners are advised to consult with their own legal or financial counsel and to conduct their own due diligence before making any financial decisions.The hosts, Tait Duryea and Ryan Gibson, do not necessarily endorse the views of the guests featured on the podcast, nor have the guests been comprehensively vetted by the hosts.Under no circumstances should any material presented in this podcast be used or considered as an offer to sell, or a solicitation of any offer to buy, an interest in any investment. Any potential offer or solicitation will be made exclusively through a Confidential Private Offering Memorandum related to the specific investment. Access to detailed information about the investments discussed is restricted to individuals who qualify as accredited investors under the Securities Act of 1933, as amended.Listeners are responsible for their own investment decisions and are encouraged to seek professional advice before investing.

In this episode of Charlie and Steve Watch Stuff, we welcome TV and Film Writer Billy Lorusso to the program to discuss the 2006 Drama/Comedy/Classic, "The Devil Wears Prada". Along with Billy, the boys cover plot points, themes, what they loved, what they would have changed, and what still has them gagged all the way in 2024. At the end of the discussion, they rank the film in a scale of 5 Birkin Bags.A special thank you to Billy for joining us, be sure to follow him on Instagram and X, and give his writing samples a look! Thanks for being a part of the Charlie and Steve Watch Stuff Community - Follow us on Instagram and share what your Birkin Bag Ratings are for this film, and tell us about what you're watching right now! 

Il resoconto di due anni di guerra in Ucraina attraverso le parole di Marta Ottaviani, giornalista esperta di Russia e autrice di “Brigate russe. La guerra occulta del Cremlino contro l'Occidente” (Bompiani)

Jenna Lorusso from the University of Limerick, Ireland, Hayley Morrison from the University of Alberta, and Ashley Johnson from Queens University join to discuss the article Scholarship and Grant Writing in Physical and Health Education: Top Ten Tips for Graduate Students published with Hayley Morrison and Ashley Johnson. We talk about tips on finding and writing scholarships and grants for HPE graduate students and early career scholars. Full Cite: Lorusso, J. R., Morrison, H. J., & Johnson, A. M. (2023). Lorusso, J. R., Morrison, H. J., & Johnson, A. M. (2023). Ten top tips on scholarship and grant writing for graduate students in physical and health education. Revue phénEPS/PHEnex Journal, 13(3). Twitter: @jennaRLorusso @Ms_HMorrison @PHECanadaRC --- Support this podcast: https://podcasters.spotify.com/pod/show/pwrhpe/support

Dylan Scanlon from Deakin University, Australia, and Jenna Lorusso from the University of Limerick in Ireland join to discuss the article Understanding (and extending) the conceptual boundaries of policy research in physical education published with Melody Viczko. We talk about the policy research in school-based physical education between 2010 and 2020. Full Cite: Scanlon, D., Lorusso, J., & Viczko, M. (2023). Understanding (and extending) the conceptual boundaries of policy research in physical education: A scoping review. European Physical Education Review, 1-21. https://10.1177/1356336X23121039 --- Support this podcast: https://podcasters.spotify.com/pod/show/pwrhpe/support

This week on The Midlife Makeover Show, it's all about embracing the possibilities of midlife as a time of freedom, self-awareness and sharing your gifts. I interviewed inspiring guest Maryann LoRusso, creator of the More Beautiful Project. We discuss moving past fears about aging to focus on gains like wisdom and perspective. Maryann shares how she's chosen fulfilling work over perfectionism and spotlights diverse women's stories. Tune in for an uplifting take on midlife as a time to pursue your purpose. Enjoy!  

Episode 167 of the Fit Father Project Podcast is all about the power of support and how the right people around us can get us through anything.In this episode, you'll meet Harry Lorusso, a man with a unique and incredible story to tell.In March 2019, at the age of 33, Harry was diagnosed with glioblastoma, one of the most complex, deadly, and treatment-resistant forms of cancer. He underwent a year of treatment at UPMC Hillman Cancer Center and was enrolled in a trial that injected a virus in his tumor and included radiation, oral chemotherapy, and IV immunotherapy. The average life expectancy of a glioblastoma diagnosis is around 14-16 months. Four years have passed since Harry's treatment, and he's had no evidence of the disease since! Harry deeply believes the most essential part of beating this disease was the power of support he got from his family, friends, and medical team. Once Harry's treatment was finished, he decided to shift his focus onto others battling this disease and founded The Outlier Fund with his wife, Dana. The Outlier Fund is a 501(c)3 dedicated to bringing hope to those impacted by glioblastoma by creating community, raising awareness and funds for impactful research. These days, Harry loves spending time with Dana and their two-year-old son Wylie and “doing hard things.” In May of 2022, he completed his first 26.2-mile marathon and, in April of 2023, finished 9th overall in his first 33-mile off-road ultramarathon through the Blue Ridge Mountains.This is an incredible conversation with a man we can all learn a lot from!In this episode, you'll learn about: Harry's life and health story.His glioblastoma diagnosis and how he dealt with it.The importance of having a solid support system around you.How Harry beat glioblastoma.Staying positive and focused.And so much more!So, if you want to get the most from your health and fitness efforts, listen to this episode on the power of support, take some notes, and check out FF30X! More From Harry:The Outlier FundInstagramFacebookWhat is FF30X?FF30X is a simple, sustainable, and specific weight loss program designed especially for busy men over 40. With short metabolic training workouts, an easy-to-follow meal plan, and an accountability team there for you at every step, FF30X can help you lose 30, 40, or even 50+ lbs — even if you've never picked up a weight in your life. Click here to see what you get when you join the FF30X program today!If you loved what you heard on the Fit Father Project Podcast, please follow, rate, and review it on Apple Podcasts.You can also listen to the show on:Spotify

A pastor's parting words to the church.

Aldo Pagano"Erba d'annata"Edizioni Piemmewww.edizpiemme.itÈ un lunedì mattina di metà dicembre con un freddo cane e una gran tramontana quando il sostituto procuratore Emma Bonsanti arriva nella periferia di Bari, fuori da un capannone dove è stato segnalato il cadavere di un ragazzo della Bari bene. Il sovrintendente capo della polizia Michele Lorusso la informa che la vittima è Giorgio De Santis, ventitreenne, studente in legge, praticante notaio e figlio di noti ristoratori locali. La vittima è stesa a terra, fuori dal capannone, il corpo segnato da fratture multiple provocate dall'impatto al suolo dopo un volo di una decina di metri dal colmo del tetto. Disgrazia, suicidio, omicidio: il medico legale non esclude nessuna ipotesi. Spetta a Emma accertare la verità. Il fatto è che Emma non ha nessuna voglia di indagare su quell'ennesima morte in cui è incappata; è in un momento di fragilità, si sente sola, vuota, inutile e non ha energie da spendere per quello che pensa essere il gesto volontario di un ragazzo problematico. Quando, però, Lorusso scopre che ci sono molte cose che non tornano nella vita e nella morte di De Santis - un rave party svoltosi proprio nel capannone, una lite furiosa a pochi minuti dalla scomparsa, il progetto di un matrimonio da cui forse voleva tirarsi indietro e la coltivazione, non proprio legale, di marijuana - Emma capisce che è necessario svegliarsi dal torpore e mettere, di nuovo, tutta se stessa in un caso che di suicidio non sembra avere più neanche l'ombra. Aldo Pagano è un vero maestro del giallo e riesce a coniugare la passione per il genere e per le indagini con una magistrale interpretazione degli stati d'animo umani.Aldo Pagano, nato a Palermo nel 1966, ha vissuto a lungo a Roma, Bari, Milano, Como. Ex giornalista ed ex sommelier, fra le tante altre cose che ha fatto gli piace ricordare gli anni nelle pubbliche relazioni e il lancio di un fichissimo chiosco da spiaggia. La protagonista di Motivi di famiglia, il pubblico ministero Emma Bonsanti, è apparsa anche nel suo primo romanzo, La trappola dei ricordi, pubblicato nel 2015 da Todaro e in corso di ripubblicazione per Piemme.IL POSTO DELLE PAROLEascoltare fa pensarewww.ilpostodelleparole.itQuesto show fa parte del network Spreaker Prime. Se sei interessato a fare pubblicità in questo podcast, contattaci su https://www.spreaker.com/show/1487855/advertisement

Nick Lorusso was drafted by the Mets this year out of University of Maryland and got right to work with the St. Lucie Mets. In this conersations he lays out his draft night, talks about going to games as a kid at Shea Stadium and Citi Field and does some Big 10 talk with Jon “Big 10 League Guy Myself” Baron. Great listen for anyone who ants to know more about what the Mets have cooking in player dev! To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

From Masuk High School in Monroe, Ct to Villanova University to the University of Maryland to the New York Mets. Nick Lorusso has been on a journey that very few get to experience. His trek has involved hard work, self-discipline, passion, persistence, a continuing desire to improve, and a big commitment to learning. Listen in as Nick recounts his experiences while climbing the ladder to become an MLB draft pick of the NY Mets. 

Episode 93 of the Fit Mother Project Podcast is all about the power of support and how the right people around us can get us through anything.In this episode, you'll meet Harry Lorusso, a man with a unique and incredible story to tell.In March 2019, at the age of 33, Harry was diagnosed with glioblastoma, one of the most complex, deadly, and treatment-resistant forms of cancer. He underwent a year of treatment at UPMC Hillman Cancer Center and was enrolled in a trial that injected a virus in his tumor and included radiation, oral chemotherapy, and IV immunotherapy. The average life expectancy of a glioblastoma diagnosis is around 14-16 months. Four years have passed since Harry's treatment, and he's had no evidence of the disease since! Harry deeply believes the most essential part of beating this disease was the power of support he got from his family, friends, and medical team. Once Harry's treatment was finished, he decided to shift his focus onto others battling this disease and founded the Outlier Fund with his wife, Dana. The Outlier Fund is a 501(c)3 dedicated to bringing hope to those impacted by glioblastoma by creating community, raising awareness and funds for impactful research. These days, Harry loves spending time with Dana and their two-year-old son Wylie, and “doing hard things.” In May of 2022, he completed his first 26.2-mile marathon and, in April of 2023, finished 9th overall in his first 33-mile off-road ultramarathon through the Blue Ridge Mountains.This is an incredible conversation with a man we can all learn a lot from!In this episode, you'll learn about: Harry's life and health story.His glioblastoma diagnosis and how he dealt with it.The importance of having a solid support system around you.How Harry beat glioblastoma.Staying positive and focused.And so much more!So, if you want to get the most from your health and fitness efforts, listen to this episode on the power of support, take some notes, and check out FM30X! More From Harry:The Outlier FundInstagramFacebookWhat is FM30X?FM30X is a simple, sustainable, and specific weight loss program that is designed especially for busy women over 40. With short metabolic training workouts, an easy-to-follow meal plan, and an accountability team that is there for you at every step, FM30X can help you lose 30, 40, or even 50+ lbs — even if you've never picked up a weight in your life. Click here to see what you get when you join the FM30X program today!If you loved what you heard on the Fit Mother Project Podcast, please follow, rate, and review it on Apple Podcasts.You can also listen to the show on:Spotify

ll sogno di lavorare come medico nei Paesi più poveri e in difficoltà ha spinto Vincenza Lorusso a partire giovanissima e a lavorare per vent'anni tra Africa e Sud America.

On a new episode of the “Amazin' But True” podcast with Jake Brown and Nelson Figueroa, the guys open the show talking about the Mets losing two out of three games to the Dodgers. They discuss Sunday's walk-off win, Max Scherzer's great outing, the offensive struggles, Saturday's circus, Buck Showalter's poor decision making and what has changed on the coaching side. (28:28) Mets 9th round draft pick Nick Lorusso then joins the show. Lorusso talks about getting drafted by the Mets, the draft process, his growth at Maryland, putting up historic numbers his senior season, his player comparison and he answers some rapid fire questions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pregame Interview: Nick Lorusso | 5-19-23 by Maryland Baseball Network

For women journeying through midlife and navigating the fun (and not so funny) things we experience, it's good to have a girlfriend to go with you. I cannot think of a better person to take this trip with than Maryann LoRusso.A journalist and creator of the More Beautiful Project, which includes an online magazine, podcast, and newsletter for women, Maryann is your gal to dish the raw, and real deal of midlife.With three decades of experience as an editor at fashion publishing companies such as Fairchild/Conde' Nast and Time Inc., Maryann now has a mission to change the conversation around aging and inspiring women to enjoy their best years yet.LINKS TO THIS EPISODE:Maryann's website: morebeautifulpodcast.comHer blog: https://morebeautifulpodcast.com/blog/Direct link to her podcast: https://morebeautifulpodcast.com/podcast/FOLLOW her on Instagram: morebeautifulprojectBEAUTIFUL SECOND ACT LINKS:The website: beautifulsecondact.comJoin the Facebook Group: https://www.facebook.com/groups/beautifulsecondactGET MY FREEBIE: 10 Tips After 50Follow me on Instagram: beautiful_second_actJOIN THE BSA MEMBERSHIPGet my book: AFTER THE FIREWANT TO SPONSOR THE SHOW?Click her to learn moreThank you so much for listening. To support this show, please consider leaving a REVIEW, a RATING, and don't forget to SUBSCRIBE or FOLLOW from wherever you listen so you won't miss a single episode.Xoxo ~Patti

Midlife offers us a special time to truly sink into what we want to do. It's up to us to lean in and go for it without fear. Are you feeling stuck in a rut? Are you ready for a change but need help figuring out where to start? Stepping out of your comfort zone and embracing your age are great ways to jumpstart your life and get back on track. This week, episode 106 of The Jen Marples Show is about Changing the Narrative Around Midlife with Maryann LoRusso.Maryann LoRusso is a San Francisco-based journalist with over 25 years of experience covering fashion, culture, and lifestyle. A former executive (editor-in-chief) at Fairchild Publications/Condé Nast and editor at Time Inc., she has written and edited miles of editorial copy, spoken at global fashion-industry events, and interviewed hundreds of CEOs, celebrities, change makers, and fashion icons—including Vera Wang, Manolo Blahnik, Anna Sui, Kenneth Cole, and Kate Spade. Maryann's most recent endeavor is More Beautiful, a podcast and website for women navigating midlife.Maryann and I discuss the following:How society has traditionally made women feel like they expire after turning 40.The male gaze and how for decades, movies, advertising, and articles came only from the male perspective (think Mrs. Roper from Three's Company!)The possibility of meeting amazing and like-minded people at midlife.How to step to the edge and outside of your comfort zone. Maryann's five points for storytelling which will impact how you show up, share what you're all about, and what you have to offer.Remember, you still have so much life to live. Don't let anyone hold you back from pursuing your dreams!Thank you for listening! If you enjoyed this episode, take a screenshot of the episode to post in your stories and tag me on Instagram @jenmarples!  And don't forget to follow, rate and review the podcast and tell me your key takeaways!Learn more about Jen Marples at https://www.jenmarples.com/ Unedited AI Transcript HereCONNECT WITH MARYANN LORUSO:WebsiteTwitterLinkedInInstagramPodcastCONNECT WITH JEN MARPLES:Subscribe to my NewsletterJoin Jen's Private, Free Facebook GroupSend Jen a Voice Message InstagramLinkedInTikTok Work with Jen! Website

Neil has been broadcasting from Wynn Las Vegas and it is breathtakingly beautiful. Executive Chef Mark LoRusso talks SW Steakhouse and so much more.

In this week's episode of The Mental Matchup, Kat and Schuyler are joined by Jarett LoRusso. Jarett grew up in Purcellville, VA, and is currently getting his Master's degree at the University of Richmond. Throughout the episode, Jarett walks us through his recruiting process, being injured for the majority of his career, and how his relationships benefitted when he opened up about his feelings.

Spencer talks with an amazing father of 2, THAT Dad at Disney, former jersian, and one of my best friends. A self proclaimed Limousine Ridin', Jet Flying, Kiss Stealin', Wheelin' Dealin Marathon Runnin Dad of 2 kids, Dominick Lorusso…Dominick drops some amazing insights on marathon running, fatherhood, and what really matters!Don't forget to subscribe, rate and review so we can push this podcast to the moon and get it into every Dad's hands across the world!More Information:To keep up with Dominick (THAT Dad at Disney) and learn how to manage your Disney trips without any headaches, follow him at: https://www.instagram.com/thatdadatdisney/Thanks For Tuning In! Thanks so much for being with us on this episode. If you enjoyed this episode with Dominick, please share it with your friends so we can push this podcast to the moon and get it into every Dad's hands across the world!Don't forget to subscribe to the show wherever you get your podcasts from to get automatic episode updates for The Fit Father Podcast!And, finally, please take a minute to leave us an honest review and rating. They really help us out when it comes to the ranking of the show and I make it a point to read every single one of the reviews we get. Thanks for listening!If you'd like to keep in touch with us: The Fit Father Podcast: https://go.gallofitness.com/fit-father-podcastThe Fit Father Podcast on IG: https://www.instagram.com/fitfatherpodcast/Gallo Fitness - Busy Dad Blueprint: https://www.facebook.com/groups/busydadblueprintSpencer on FB: https://www.facebook.com/spencer.galloSpencer on IG: https://www.instagram.com/spencergallo_/

In this episode of the EMJ Podcast, Brigitte Scott hosts Gilles Freyer, Medical Oncologist, Lyon University Hospital, France; and Domenica Lorusso, Associate Professor of Obstetrics and Gynecology, Catholic University of Rome, Italy, and responsible for Clinical Research Development at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Freyer and Lorusso provide expert perspectives on the research outcomes, updates, and advancements in ovarian cancer management that were presented at the European Society for Medical Oncology (ESMO) Congress 2022, which took place on 9th–13th September, in Paris, France. This podcast was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in ovarian cancer care.

On this episode we get to sit down with the talented artist Joseph Lorusso! Joseph takes us through his journey and how his Italian background helped influence his work, his time at the Kansas City Art Institute, painting for Hallmark, his jaw-dropping, magnetic pieces and so much more!

Big episode 33 has me sitting down with the Mayor of Oyster Bay, Mr. Alex LoRusso. I first got introduced to Alex through Empire Nutrition in late 2019 / 2020. We instantly became tight during the pandemic and he later told me about his almost fatal car accident in 2017. I knew instantly I had to have him on the podcast to bring awareness to TBIs (Traumatic Brain Injuries ) and the mentality of never giving up. A true warrior in the flesh, Alex also owns Empire Nutrition in Syosset. If you can, please share the cast with friends and family. His story needs to be heard.

Joe is out here to let the people know about E-Commerce business and Health. Asking the question, how can we make the most amount of money with the least amount of work? He wants us to progress our bodies and mind, that's the vibe.You can Find Joe Here: https://www.instagram.com/cupofjoe1794/Ayoo Chill Link: https://linktr.ee/ayoochillpodcast

86: Scott McGee on Hollywood's Greatest Stunts • Ed Lorusso on a Wallace Reid DVD Kickstarter by Michael Gebert

This week we are joined by special guest, Joe LaRusso. Joe is a pilot, aviation attorney, and aeromedical reform advocate. During his time as a flight instructor he saw a need for dedicated representation for pilots. Joe is extremely knowledgeable on the FAA aeromedical policies and law. Through his work he has discovered how flawed the system truly is, and has fought tirelessly to help pilots who have been wronged by it. In addition, he is also a active contract pilot and having flown several Citation jets including the M2 and the C|3+ also including a atmospheric research jet. From flying through hurricanes to sitting in court, you can listen to it all here, on the pilots pandemic. SOCIAL LINKS- Instagram: https://Instagram.com/thepilotspandemic https://instagram.com/emneonicon https://Instagram.com/thefitaviatrix Link for aeromedical reform petition: https://www.change.org/apilotspandemic WEBSITE: https://msha.ke/thepilotspandemic/ --- Support this podcast: https://anchor.fm/thepilotspandemic/support

Harry Lorusso was diagnosed with GBM at just 33 years old. He said of his diagnosis, "No one changes when things are easy. The type of people my wife and I are today, we wouldn't have become without GBM." A week after his diagnosis, he and his fiancé got married. A year later they had a son. And now they've started the Outlier Fund. Three years in and Harry is not only in "no evidence" phase at 36 years old, but he just ran 26 miles in the Pittsburgh Marathon! Harry talks to me about the clinical trial that has given him three years thus far, the importance of attitude, gratitude, and viewing his diagnosis as a blessing. It's an episode you won't want to miss!! **Also, don't miss Game On Glio's documentary film shot on location with Harry as he ran the Pittsburgh Marathon. The full special video can be found on our YouTube page   Learn more about our sponsors on our website and in the podcast:  GT Medical Technologies-Gamma Tile Highmark BCBS of WNY

Full Episode Release on 5/26/2022   Watch the video version of this episode on Youtube Channel, The Game on Glio Podcast!   Visit TheGameOnGlioPodcast.com for more information about Harry Lorusso and other past guests